• Forum
  • Aktiemarkeder
    • MarkederRealtidskurser, indekser og markedsudvikling
    • BørskalenderKommende resultater, noteringer og virksomhedsbegivenheder
    • UdbyttekalenderKommende og tidligere udbytter
  • Selskaber
    • SelskaberGennemse og filtrer den fulde liste over børsnoterede selskaber
    • OpdagInspiration til din næste investering
    • BørsnoteringerNye noteringer og kommende børsintroduktioner
    • Invitationer til generalforsamlingerDatoer for generalforsamlinger og aktionærinformation
  • Aktieanalyse
    • ResearchEkspertaktieanalyse og anbefalinger
    • ArtiklerNyheder, indsigter og markedskommentarer
    • inderesTVVideocenter for aktieanalyse, forskning og ekspertkommentarer
    • TransskriptionerFuldstændige udskrifter af resultatopkald og investormøder
    • AktieoversigtSammenlign nøgletal og udvikling på tværs af flere aktier
Find os på de sociale medier
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Vores team
  • Karriere
  • Inderes som en investering
  • Tjenester for børsnoterede virksomheder
Vores platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer

Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.

Pressemeddelelse

The first order for mobile systems in Denmark demonstrates the strength of Medclair's growth model

Medclair

Medclair has received an order for three mobile systems from Region Hovedstaden in Denmark. The customer already uses the company's central system, making the deal a clear example of Medclair's ability to generate growth through upselling and expansion with existing customers. With solutions installed or ordered at seven hospitals in Denmark, Medclair has established a strong foothold in a market where more than 20 hospitals use nitrous oxide, while significant growth opportunities exist within both healthcare and dentistry.

Medclair's business model is based on initially establishing the company's solutions within a specific department at a hospital, and subsequently expanding to further clinical environments where nitrous oxide is used, such as maternity, pediatrics, emergency departments, and dentistry. For Medclair, a hospital does not represent a single business opportunity, but rather a platform for long-term growth. An initial installation can thus evolve into multiple orders within the same hospital, extend to the region's other hospitals and operations, and create the conditions for continued expansion.

The expansion in Region Hovedstaden, where the customer complements its existing installation of Medclair's central system in maternity care with three mobile systems, illustrates the strategy in practice.

"The deal demonstrates the strength of our growth model. Once we have established ourselves within a hospital, opportunities are created to grow through additional departments, additional solutions, and further orders. Region Hovedstaden is a clear example of how we build long-term value by developing existing customer relationships”, says Jonas Lundh, CEO of Medclair.

For further information, please contact:
Jonas Lundh, Medclair AB (publ), Phone: +46 76 193 90 90, Email: jonas.lundh@medclair.com

About Us
Medclair is a Swedish cleantech company and a leader in safe and sustainable nitrous oxide management. With operations in twenty countries, Medclair provides innovative solutions that significantly reduce the climate impact of nitrous oxide while improving workplace safety.

The company is listed on NGM Nordic SME. For more information, please visit www.medclair.com.

Attachments
The first order for mobile systems in Denmark demonstrates the strength of Medclair's growth model